PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

35,530 stories, page 76 of 593

Advanced search
๐Ÿ‡บ๐Ÿ‡ธRegulatoryfederalregister.gov

Medical Devices; Gastroenterology-Urology Devices; Classification of the Implanted Tibial Electrical Urinary Continence Device

The Food and Drug Administration (FDA) is classifying the implanted tibial electrical urinary contin...

Federal RegisterOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryfederalregister.gov

Medical Devices; Radiology Devices; Classification of the Vaginal Hydrogel Packing System

The Food and Drug Administration (FDA) is classifying the vaginal hydrogel packing system into class...

Federal RegisterOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryfederalregister.gov

Medical Devices; General Hospital and Personal Use Devices; Classification of the Whole Room Microbial Reduction Device

The Food and Drug Administration (FDA) is classifying the whole room microbial reduction device into...

Federal RegisterOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryfederalregister.gov

Notice of Supplemental Funding, Medicare Rural Hospital Flexibility Program

HRSA is providing additional fiscal year 2026 funding under the Medicare Rural Hospital Flexibility...

Federal RegisterOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryfederalregister.gov

Announcing the Intent To Award a Single-Source Supplement to the Senior Medicare Patrol (SMP) Resource Center

The Administration for Community Living (ACL) announces the intent to award a single-source suppleme...

Federal RegisterOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: CycloSPORINE, Modfied

Official structured record identifier: 5baaf78c-90f6-abcf-52c8-814490f3cf9f.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Leader Classic Clean Dandruff

Official structured record identifier: 5b22537d-d09c-5bd6-e063-6294a90a48ff.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Medique Diotame Instydose

Official structured record identifier: 5b214128-6980-0f84-e063-6294a90ad8ca.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: JenGufun LIDOCAINE KNEE Patch

Official structured record identifier: 5b1d8508-b993-7a8d-e063-6294a90ae306.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: OJIOG WART REMOVER Cream

Official structured record identifier: 5b1cff55-0478-62d2-e063-6394a90abfc7.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Dcsily Liquid Wart Corn Remover

Official structured record identifier: 5b1bf2f7-422f-8713-e063-6394a90adee3.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: HOMWIS Anti-itch Cream

Official structured record identifier: 5b1a68f5-5f5d-7e1a-e063-6294a90a8a92.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: BCBCYC Numbing Cream

Official structured record identifier: 5ab36566-ba2f-06ef-e063-6394a90a71b5.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Chlorhexidine Gluconate Oral Rinse

Official structured record identifier: 583986f1-1cce-21c3-e063-6394a90aed1f.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Neutrogena Ultra Sheer Body Mist Sunscreen Broad Spectrum SPF 45

Official structured record identifier: 51f3d6ca-3189-4380-9afb-4259ba878274.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Levothyroxine sodium

Official structured record identifier: 4c903249-69e9-4168-a9d1-22e6c2c1eb22.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: JAYTHARI Oral Suspension

Official structured record identifier: 43f3890e-0b1d-9bb5-e063-6294a90aa622.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Hydra Finish SPF 15

Official structured record identifier: 4047e8ec-834a-41e6-a144-5649a7718de4.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Pepto Gas plus Bloating

Official structured record identifier: 3d80a5bb-0ed0-769a-e063-6394a90ac50c.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Relevea Pain Relief Patch

Official structured record identifier: 3ce49b85-e9e3-e33c-e063-6294a90a6dbf.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Pur Confort SPF 15

Official structured record identifier: 2fe0656f-f924-48da-91bf-d6f3d98e8fd9.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: unspecified product

Official structured record identifier: 2b6a175f-238a-48d9-b99b-5e11fe44d359.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Pepto Nausea Motion Sickness

Official structured record identifier: 29a1bd1e-d0e0-478f-e063-6394a90ab0aa.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: LIDOCAINE HYDROCHLORIDE

Official structured record identifier: 23c8f711-e458-479a-9ab0-dcc851311e24.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Esmolol Hydrochloride

Official structured record identifier: 1f5707f2-a8a7-4a5f-b846-64585b5e3f9f.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Glatiramer Acetate

Official structured record identifier: 1ec10223-880d-402f-a759-9cd179bf09de.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Cough and Cold HBP

Official structured record identifier: 1ea07a01-8779-48c2-a287-b7be866cce7b.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Gabapentin

Official structured record identifier: 167d8b87-506c-4293-9579-563feaa71583.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: Xarelto

Official structured record identifier: 10db92f9-2300-4a80-836b-673e1ae91610.

openFDA Drug LabelsOriginal source
๐Ÿ‡บ๐Ÿ‡ธRegulatoryopen.fda.gov

Drug label update: METOPROLOL TARTRATE

Official structured record identifier: 0ca72c89-82c5-4b31-b515-1a8b8e82ec59.

openFDA Drug LabelsOriginal source
๐ŸŒResearcheuropepmc.org

A Dual-Species Plant-derived Extracellular Vesicle and Growth Factors Formulation for Hair and Scalp Care: A Randomized, Placebo-controlled Study

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Industry updates from the field of stem cell research and regenerative medicine in July 2025

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

eGFR- and Potassium-Guided Stewardship of SGLT2 Inhibitors and Finerenone in Albuminuric Chronic Kidney Disease Associated with Type 2 Diabetes.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Jingtong Granules for Cervicogenic Headache: Clinical Efficacy, Mechanisms, and Translational Potential.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Alzheimer's prevention drug trial: is a "statin for the brain" on the horizon?

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Successful Healing of a Chronic Distal Toe Ulcer with Tendon Exposure Using the Topical Macrophage Regulator ON101.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Potential of plasma metagenomic next-generation sequencing to guide antibiotic therapy in acute necrotizing pancreatitis with early fever: a prospective multicenter cohort study.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Author Correction: Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trial.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Leveraging neural network models for drug repurposing: a case study on cardiac hypertrophy.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Vanderbilt Integrated Community TMS for Opioid Recovery (VICTORY): Study protocol for a randomized, controlled trial of non-invasive brain stimulation to reduce craving in people with opioid use disorder.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Loberamisal for Acute Ischemic Stroke: The LAIS Randomized Clinical Trial.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Clinical trial barriers in neurostimulation for pediatric drug-resistant epilepsy.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Parenting Process of Mothers Raising Low Birth Weight Infants Without Medical Technology Dependence After Discharge from Neonatal Intensive Care Units: A Qualitative Study.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

Vancomycin rescues sensitivity to isoniazid in clinical isolates of drug-resistant <i>Mycobacterium tuberculosis</i>.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma.

Europe PMCOriginal source
๐ŸŒResearcheuropepmc.org

ADVANCE-ID bacterial and fungal infections review: antimicrobial resistance research updates.

Europe PMCOriginal source
๐ŸŒResearchdoi.org

A Retrospective Analysis of Clinical Outcomes Following Human Deviations from Algorithmic Recommendations

CrossrefOriginal source
๐ŸŒResearchdoi.org

Short-Term Efficacy of Tegoprazan Compared With Esomeprazole in Patients With Non-Erosive Reflux Disease and Nocturnal Heartburn Symptoms: A Double-Blind, Randomized Controlled Trial

CrossrefOriginal source
๐ŸŒResearchdoi.org

The Function of Angiotensin-Converting Enzyme Inhibitors in Chronic Kidney Disease: Pathophysiological Mechanisms and Implications for Practice

CrossrefOriginal source
๐ŸŒResearchdoi.org

Proposals for Individually Safe and Realistic Correction of Antipsychotics in Hospitalized Patients with Schizophrenia: A Prescription Survey at Nagoya University Hospital

CrossrefOriginal source
๐ŸŒResearchdoi.org

Development of a Rubric for Assessing Essential โ€œBasic Social Skillsโ€ Required at the Time of Employment and Its Evaluation in Clinical Training

CrossrefOriginal source
๐ŸŒResearchdoi.org

Clinical Evaluation of Reduced-Dose versus Standard-Dose Remdesivir in Patients with eGFR < 30 mL/min/1.73m<sup>2</sup>: Effectiveness and Safety

CrossrefOriginal source
๐ŸŒResearchdoi.org

Characteristics of Medication Errors Prevented by Community Pharmacists During Transition of Care

CrossrefOriginal source
๐ŸŒResearchdoi.org

Pharmacist Secondment, Implementation of Ward-based Pharmaceutical Services, and Challenges in Medication Information Sharing during Care Transitions

CrossrefOriginal source
๐ŸŒResearchdoi.org

Continuous Intervention by an Antimicrobial Stewardship Pharmacist Contributes to Successful Treatment of a Brain Abscess: A Case Report

CrossrefOriginal source
๐ŸŒResearchdoi.org

Identification of Risk Factors for Lithium-Associated Renal Impairment: A Multicenter Retrospective Cohort Study

CrossrefOriginal source
๐ŸŒResearchdoi.org

Evaluation of Treatment Continuation and Tolerability Using the Urine Protein-to-Creatinine Ratio (UPC Ratio) as a Criterion for Proteinuria in Patients with Colorectal Cancer Receiving Bevacizumab

CrossrefOriginal source
๐ŸŒResearchdoi.org

Implementation of the Electronic Tracing Report System and Evaluation of its Usefulness

CrossrefOriginal source
๐ŸŒResearchdoi.org

Introduction

CrossrefOriginal source